Huntington director granted HBAN stock awards
Tate Jeffrey L. reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Tate Jeffrey L. reported acquisition or exercise transactions in this Form 4 filing.
Huntington Bancshares director Jeffrey L. Tate received stock-based compensation rather than buying shares on the market. On April 1, 2026, he was granted 503.864 shares of common stock directly and 49.598 shares credited to a Director Deferred Compensation Plan, both at no cash cost.
After these awards, Tate directly held 113,614.853 common shares and had 5,158.695 shares credited in the deferred compensation arrangement. A footnote states that the filing should not be taken as an admission that he is the beneficial owner of all reported securities.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 503.864 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 49.598 | $0.00 | $0.00 |
Footnotes (1)
- F1. The filing of this statement shall not be construed as an admission that the undersigned is, for the purpose of Section 16 of the Securities and Exchange Act of 1934 or otherwise, the beneficial owner of the securities.
Key Figures
Key Terms
Director Deferred Compensation Plan financial
beneficial owner regulatory
Section 16 of the Securities and Exchange Act of 1934 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Jeffrey L. Tate report in this HBAN Form 4 filing?
What is the Director Deferred Compensation Plan mentioned in the HBAN filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.